Novartis AG (LTS:0K9E)
$ 104.615 -1.015 (-0.96%) Market Cap: 209.73 Bil Enterprise Value: 227.87 Bil PE Ratio: 12.44 PB Ratio: 5.03 GF Score: 80/100

Novartis AG R&D Day (Virtual) Transcript

Dec 02, 2021 / 01:00PM GMT
Release Date Price: $75.12 (-0.77%)
Operator

Good morning, good afternoon, ladies and gentlemen, and welcome to the Novartis R&D Day 2021. (Operator Instructions) And the event is being recorded. (Operator Instructions) A recording of the full event will be available on our website shortly after it ends.

With that, I would now like to hand over to Samir Shah, Global Head of Investor Relations. Please go ahead.

Samir Shah
Novartis AG - Global Head of IR

Thank you very much, and good morning and good afternoon to everybody. A big welcome and thank for taking part in this R&D event from Novartis. The information presented today contains forward-looking statements that involve known and unknown risks, uncertainties and other factors. These may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. For a description of some of these factors, please refer to the company's Form 20-F and its most recent quarterly results on Form 6-K that respectively were filed with and furnished to the U.S. Securities and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot